Krokan H, Lechner J, Krokan R H, Harris C C
Mutat Res. 1985 Sep;146(2):205-9. doi: 10.1016/0167-8817(85)90012-4.
Normal human bronchial epithelial cells cultured in serum-free medium were exposed to low doses o N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to examine whether increased cellular resistance and increased activity of the DNA-repair enzyme O6-methylguanine-DNA methyltransferase could be induced. After treatment with single doses of MNNG a dose-dependent decrease in O6-methylguanine-DNA methyltransferase activity was observed, as expected for this unique repair system. The activity recovered to the starting level in about 24 h when a dose that consumed approximately 65% of the enzyme activity (0.2 micrograms/ml) was given, but did not exceed the activity in the untreated control. Furthermore, treatment every 6 h for 4-5 days with non-toxic concentrations of MNNG (0.04-0.12 micrograms/ml) did not increase O6-methylguanine-DNA methyltransferase activity. Neither was cell survival following a range of challenge doses significantly increased. Our data suggest that human bronchial epithelial cells do not adapt to MNNG.
将在无血清培养基中培养的正常人支气管上皮细胞暴露于低剂量的N-甲基-N'-硝基-N-亚硝基胍(MNNG),以检查是否可以诱导细胞抗性增加和DNA修复酶O6-甲基鸟嘌呤-DNA甲基转移酶的活性增加。用单剂量的MNNG处理后,观察到O6-甲基鸟嘌呤-DNA甲基转移酶活性呈剂量依赖性下降,这对于这种独特的修复系统来说是预期的。当给予消耗约65%酶活性的剂量(0.2微克/毫升)时,活性在约24小时内恢复到起始水平,但不超过未处理对照中的活性。此外,用无毒浓度的MNNG(0.04-0.12微克/毫升)每6小时处理4-5天,并没有增加O6-甲基鸟嘌呤-DNA甲基转移酶的活性。一系列攻击剂量后的细胞存活率也没有显著增加。我们的数据表明,人支气管上皮细胞不会对MNNG产生适应性。